TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
Condition(s):Postpartum HemorrhageLast Updated:December 7, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Postpartum HemorrhageLast Updated:December 7, 2023Recruiting
Condition(s):Diabetic Foot Infection; Non-healing Wound; Non-healing Diabetic Foot UlcerLast Updated:December 8, 2023Recruiting
Condition(s):Diabetic Foot Infection; Non-healing Wound; Non-healing Diabetic Foot UlcerLast Updated:September 28, 2023Active, not recruiting
Condition(s):Deferred Umbilical Cord ClampingLast Updated:May 17, 2018Terminated
Condition(s):Fetal Conditions; Maternal; Procedure; Pregnancy Related; Twin to Twin Transfusion Syndrome; In Utero Procedure Affecting Fetus or Newborn; Chorion; Abnormal; Twin Reversal Arterial Perfusion Syndrome; Twin Monochorionic Monoamniotic Placenta; Chorioangioma; Vasa PreviaLast Updated:February 28, 2024Not yet recruiting
Condition(s):Pre-EclampsiaLast Updated:June 28, 2021Unknown status
Condition(s):Fetal Growth RetardationLast Updated:January 25, 2023Completed
Condition(s):Intrauterine Growth RestrictionLast Updated:November 18, 2023Completed
Condition(s):Intraventricular HemorrhageLast Updated:May 24, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.